Inogen, Inc. (INGN) Research
Inogen, Inc. operates as a medical technology enterprise dedicated to designing, fabricating, and distributing oxygen concentration equipment. These cutting-edge devices are engineered to provide continuous oxygen support for patients managing persistent respiratory conditions. The company's diverse product range features the popular portable Inogen One, which efficiently draws oxygen from the surrounding atmosphere to offer an independent supply, alongside stationary Inogen At Home concentrators, Tidal Assist Ventilators, and various associated accessories. Inogen serves a broad clientele, including individual patients, medical professionals, and insurance providers, both domestically in the United States and globally. Furthermore, the company facilitates direct equipment rentals to patients. Founded in 2001, Inogen, Inc. is headquartered in Goleta, California.
Market snapshot
- Symbol
- INGN
- Price
- $6.41
- Day change
- +0.63%
- Market cap
- $173.5M
- P/E ratio
- -7.03x
- 52-week range
- 5.34-9.13
- Sector
- Healthcare
- Industry
- Medical - Devices
- Next earnings
- in 2 months
- Analyst price target
- $26.00
Peer companies
Recent insider activity
- Sahney Mira Kirti — A-Award (28081 shares) on 2026-06-05
- Jamali Vafa — A-Award (28081 shares) on 2026-06-05
- Boehnlein Glenn S — A-Award (28081 shares) on 2026-06-05
- Rider Heather D. — A-Award (28081 shares) on 2026-06-05
- Mora Elizabeth — A-Award (28081 shares) on 2026-06-05
Open Inogen, Inc. (INGN) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.